Links to all the SCAI 2022 late-breaking clinical research
The Society for Cardiovascular Angiography and Interventions (SCAI) has announced its late-breaking study presentations at its 2022 Scientific Sessions. These key presentations offer some of the latest scientific advances in interventional cardiology. The 45th annual SCAI meeting will be held in-person at the Hyatt Regency in Atlanta, Georgia, Thursday, May 19 through Sunday, May 22.
Find more detailed abstracts for the late-breaking SCAI sessions
• Intravascular Lithotripsy for Peripheral Artery Calcification: 1-year Outcomes from the Randomized Disrupt PAD III Trial. William Gray, Main Line Health.
• Distal versus Proximal Radial Artery Access for Cardiac Catheterization and Intervention: 30-day outcomes of The DIPRA study. Karim Al-Azizi, Baylor Scott & White The Heart Hospital.
• Sex Differences in Clinical Characteristics, Management Strategies and Outcomes of STEMI Patients with COVID-19. Odayme Quesada, The Christ Hospital Health Network.
• Contemporary In-Hospital Outcomes and Temporal Trends of Chronic Total Occlusion Percutaneous Coronary Interventions: Insights from the PROGRESS-CTO International Registry. Spyridon Kostantinis, Minneapolis Heart Institute, Abbott Northwestern Hospital.
• Update from the Safety Assessment of Femoropopliteal Endovascular treatment with PAclitaxel-coated Devices (SAFE-PAD) Study. Eric Secemsky, Beth Israel Deaconess Medical Center.
• No-implant interatrial shunt for heart failure: Multi-center clinical outcomes. Colin M. Barker, Vanderbilt University Medical Center.
• Clopidogrel monotherapy versus aspirin monotherapy for chronic maintenance beyond 12 months after PCI among patients with high risk of ischemic or bleeding events. Haoyu Wang, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College.
• One-Year Outcomes in an Expanded Cohort of Harmony Transcatheter Pulmonary Valve Recipients. Presented by Daniel S. Levi, David Geffen School of Medicine at UCLA.
Related SCAI News and Other Late-breaking Cardiology Studies:
New guidelines detail PFO management, including when to consider closure
VIDEO: Vaccines boosted survival among STEMI patients with COVID-19 in NACMI study — Interview with Santiago Garcia, MD
Key interventional cardiology takeaways from the SCAI 2022 conference
VIDEO: How the iodine contrast shortage is impacting interventional cath labs — Interview with Kirk Garratt, MD
TPV valves, CTO PCI and more: SCAI 2022 updates for interventional cardiologists
Links to the ACC.22 late-breaking clinical trials
Links to the late-breaking studies at Heart Rhythm 2022
How the availability of vaccines impacted outcomes among STEMI patients with COVID-19